Shu Fu

Star

Aconitum carmichaelii Debx.

Not yet clinically reviewed

Genus: Aconitum Species: carmichaelii Pinyin: Shu Fu
Sichuan (Jiangyou) Aconite Root — trade name for Fu Zi蜀附

Traditionally used for

  • Bowel health
  • Urinary & fluids
  • Pain & joints

Cautions & contraindications

  • Heart conditions
  • Toxic — professional use only
Moderate evidence · 6 studies

☯ TCM Properties

Category: warming interior
Temperature: hot
Taste: pungent, sweet
Meridians: heart, kidney, spleen
Functions:

Rescues Devastated Yang from Collapse; Tonifies Kidney Yang; Dispels Cold and Alleviates Pain

Traditional Chinese Uses

Shu Fu (salt-processed aconite slice, processed lateral root of aconite) is used in Chinese medicine to warm the Spleen and Kidney Yang, expel cold from the interior, and tonify the Fire of the Vital Gate (Ming Men). It addresses severe Yang deficiency with cold limbs and collapse, chronic Spleen-Kidney Yang deficiency with diarrhea and edema, and Wind-Cold-Damp bi syndrome with severe cold-type joint pain. Careful processing and professional supervision are essential due to its significant toxicity.

Click a node for details · double-click to expand it · Ctrl/⌘ + scroll or two fingers to zoom and pan.

Loading graph…

Botanical Description

Aconitum carmichaelii is a stout perennial herb of the Ranunculaceae family growing 60 to 150 cm tall from a paired root system consisting of a parent (mother) tuberous root and one to several daughter lateral tubers; the lateral tubers, after rigorous processing, are the source of Fu Zi (Shu Fu refers to Sichuan-origin processed lateral root). Stems are erect, simple or sparingly branched. Leaves are alternate, palmately divided into three to five deeply incised lobes, dark green and glossy above. The inflorescence is a terminal raceme of striking helmet-shaped flowers, each 3 to 4 cm tall, with five deep blue-violet to indigo sepals, the uppermost forming a tall hooded galea. Fruits are clusters of three to five follicles. All parts contain the extremely toxic diterpenoid alkaloids aconitine, hypaconitine, and mesaconitine.

Active Constituents

Aconitine

Diester diterpenoid alkaloid (C19-norditerpenoid)

Concentration: Raw lateral root approximately 184 mg/kg, falling to approximately 0.45 mg/kg after 90 minutes of steaming. The Chinese Pharmacopoeia caps the sum of aconitine, mesaconitine and hypaconitine in Hei Shun Pian and Bai Fu Pian at 0.020 percent.

The principal toxin of the drug and the reason aconite cannot be used raw. Shu Fu, the cooked aconite of prescription writing, is the same pharmacopoeial drug as Zhi Fu Zi, the processed lateral or daughter root of Aconitum carmichaelii, and is distinct from Chuan Wu, the mother root of the same plant. Aconitine binds neurotoxin site 2 of the voltage-gated sodium channel and holds the channel in the activated state, producing persistent depolarisation, early and delayed afterdepolarisations, and bidirectional ventricular tachycardia. Reported human toxic dose is around 0.2 mg and the lethal dose 2-5 mg by mouth; there is no antidote and the resulting ventricular tachyarrhythmia is frequently refractory to resuscitation. Cooking is what converts this molecule into a usable drug, which is exactly what the name Shu (cooked) asserts.

Mesaconitine

Diester diterpenoid alkaloid (C19-norditerpenoid)

Concentration: Raw lateral root approximately 736 mg/kg, falling to approximately 0.47 mg/kg after 90 minutes of steaming

Usually the most abundant of the three diester alkaloids in the raw lateral root and, with aconitine, the main driver of cardiotoxicity. It shares the same sodium-channel-opening mechanism and the same hydrolytic vulnerability at the C-8 acetyl ester.

Hypaconitine

Diester diterpenoid alkaloid (C19-norditerpenoid)

Concentration: Raw lateral root approximately 830 mg/kg, falling to approximately 3.84 mg/kg after 90 minutes of steaming

The third of the pharmacopoeial diester markers and, in several processing studies, the slowest of the three to hydrolyse. It is therefore the alkaloid most likely to persist in under-processed or under-boiled material, and is a useful indicator of inadequate preparation.

Benzoylaconine

Monoester diterpenoid alkaloid

Concentration: Raw lateral root approximately 15.7 mg/kg, rising to approximately 145 mg/kg after 90 minutes of steaming. The Chinese Pharmacopoeia requires the sum of benzoylaconine, benzoylmesaconine and benzoylhypaconine to be not less than 0.010 percent.

The C-8 deacetylated product of aconitine and the first stage of the detoxification cascade. Monoester alkaloids are reported to carry roughly one two-hundredth to one five-hundredth of the toxicity of their diester parents, an approximately three-order-of-magnitude reduction, while retaining analgesic and anti-inflammatory activity. Their rise is the analytical signature that processing has worked.

Benzoylmesaconine

Monoester diterpenoid alkaloid

Concentration: Typically the most abundant monoester alkaloid in commercial processed slices

The dominant alkaloid marker of correctly processed Fu Zi and the one usually assayed for potency. It is also the alkaloid whose intestinal permeability was shown to rise when processed aconite was combined with Fritillaria, which is the mechanistic core of one classical incompatibility.

Aconine

Amino-alcohol (amine) diterpenoid alkaloid

Concentration: Formed only under prolonged or intensified hydrolysis, after the C-14 benzoyl ester also cleaves

The endpoint of full hydrolysis, reported at roughly one two-thousandth to one four-thousandth of the toxicity of the diester parent. Its accumulation marks over-processing as much as safety: driving the reaction this far strips the analgesic monoester fraction along with the toxins, which is why processing protocols aim at a window rather than at maximum hydrolysis.

Higenamine (dl-demethylcoclaurine)

Benzylisoquinoline alkaloid

Concentration: Trace constituent; heat-stable and not destroyed by the processing that removes the diester alkaloids

A dual beta-1 and beta-2 adrenoceptor agonist and the constituent originally identified as the cardiotonic principle of Aconitum. It is largely responsible for the positive inotropic and chronotropic effect that underlies the drug's use in yang collapse and heart failure. It has been on the WADA Prohibited List as a beta-2 agonist since 2017, banned in and out of competition.

Salsolinol

Tetrahydroisoquinoline alkaloid

Concentration: Trace

A second non-diterpenoid alkaloid contributing to the positive inotropic activity of the processed drug. Like higenamine it survives processing, so the cardiotonic and the cardiotoxic fractions of Fu Zi are chemically distinct and respond differently to heat.

⚠ Drug Interactions

Amiodarone, flecainide, lidocaine, sotalol and other class I and class III antiarrhythmics

Major Evidence: Established

Aconitine-type diester alkaloids are sodium-channel openers, the pharmacological opposite of a class I blocker, and the arrhythmia they cause is triggered and catecholamine-sensitive rather than re-entrant. Aconite poisoning produces bradyarrhythmia, nodal tachycardia, bidirectional ventricular tachycardia, intraventricular block and ventricular fibrillation; ventricular tachyarrhythmia occurs in roughly 18 percent of poisoned patients and refractory ventricular tachyarrhythmia and asystole are the leading causes of death. Of 31 patients admitted to Hong Kong public hospitals with aconite root poisoning between 1989 and 1991, two died of ventricular arrhythmia, and in reported fatal cases ventricular tachycardia progressed to fibrillation and cardiac arrest refractory to resuscitation within 12 hours of ingestion. There is no antidote; amiodarone and flecainide have been used with variable success and no agent is reliably effective.

Clinical note: Do not prescribe alongside antiarrhythmic therapy outside specialist supervision. Warn every patient that perioral or limb numbness, tingling, nausea, dizziness or palpitations mean stopping the decoction immediately and going to an emergency department; those are the prodrome of aconitine cardiotoxicity, not side effects to work through.

QT-prolonging drugs (macrolides, fluoroquinolones, antipsychotics, ondansetron, methadone, tricyclic antidepressants)

Major Evidence: Probable

Aconitine and mesaconitine prolong action potential duration and provoke early and delayed afterdepolarisations in cardiac myocytes. Adding a drug that independently delays repolarisation increases the probability that a subclinical residual alkaloid load becomes a sustained ventricular tachyarrhythmia. The interaction is additive pharmacodynamic proarrhythmia rather than a metabolic one, so it does not require the two exposures to peak together.

Clinical note: Review the full medication list, including short courses such as azithromycin or levofloxacin, before dispensing. Check electrolytes, since hypokalaemia and hypomagnesaemia compound both effects, and consider deferring the aconite-containing formula until the QT-prolonging course is finished.

Digoxin and other cardiac glycosides

Major Evidence: Probable

Digoxin inhibits the sodium-potassium ATPase and raises intracellular calcium; aconitine-type alkaloids force sodium channels open and raise intracellular sodium, which drives calcium in through the sodium-calcium exchanger. The two converge on calcium overload and delayed afterdepolarisations from different directions. The toxic presentations also overlap closely (nausea, vomiting, visual and sensory disturbance, ventricular ectopy, bidirectional ventricular tachycardia), so a clinician can attribute early aconitine toxicity to digoxin and lose time.

Clinical note: Treat as a combination to avoid. If it is unavoidable, it belongs under cardiology supervision with ECG monitoring, and any new arrhythmia should be worked up for both causes rather than assumed to be glycoside toxicity.

Ban Xia (Pinellia ternata)

Major Evidence: Probable

One of the five drugs named in the classical shi ba fan (eighteen incompatibilities) rhyme as opposing the Aconitum group, and for this genus the classical rule has a real pharmacological basis rather than only a textual one. Ge and colleagues (2024) showed in rats that Pinellia ternata alters cytochrome P450 activity and thereby the metabolism of the toxic Aconitum compounds, with the incompatibility attributed to increased absorption of those compounds in vivo. Neither herb is acutely toxic at its own dose; the hazard is created by the pairing.

Clinical note: Avoid the combination. Both herbs are common enough that the pairing appears in modern prescriptions despite the classical prohibition, so audit the whole formula rather than only the aconite dose.

Bei Mu (Fritillaria cirrhosa, Fritillaria thunbergii and related species)

Major Evidence: Probable

Another of the shi ba fan five, and the best mechanistically characterised of them. When processed aconite root was combined with Fritillaria bulb, the aconite marker benzoylmesaconine showed higher intestinal permeability; Fritillaria inhibited both P-glycoprotein function and P-glycoprotein expression, with the alkaloids peimine, peimisine and imperialine identified as the inhibiting constituents. The classical incompatibility here reads as an efflux-transporter interaction that increases how much alkaloid reaches the circulation from the same oral dose.

Clinical note: Avoid. This pairing is a particular trap in cough formulae, where Bei Mu is routine and an aconite-containing base formula may be prescribed concurrently by a different practitioner.

Gua Lou (Trichosanthes kirilowii), Bai Lian (Ampelopsis japonica) and Bai Ji (Bletilla striata)

Major Evidence: Possible

The remaining three drugs of the shi ba fan Aconitum group, completing the classical set of Ban Xia, Gua Lou, Bei Mu, Bai Lian and Bai Ji. None is toxic on its own, but experimental work reports that the cardiotoxicity of Hei Shun Pian increases when it is combined with these five drugs. The mechanistic detail for these three is thinner than for Pinellia and Fritillaria, so this should be treated as a classical prohibition with supporting rather than conclusive modern pharmacology.

Clinical note: Observe the classical prohibition. The pharmacological picture is incomplete, but the downside of an unnecessary combination is a refractory ventricular arrhythmia, which is not a risk worth taking on incomplete evidence.

Chuan Wu (Radix Aconiti, the mother root of this same species), Cao Wu (Radix Aconiti Kusnezoffii), or raw unprocessed Fu Zi supplied in place of the processed drug

Major Evidence: Established

Zhi Fu Zi is the lateral (daughter) root, processed. Chuan Wu is the mother root of the same plant and Cao Wu is Aconitum kusnezoffii; both carry the same diester alkaloids and are separately dosed drugs. Prescribing them together stacks diester exposure while each individual dose looks acceptable. Hong Kong surveillance attributed herb-induced aconitine poisonings principally to Chuan Wu and Cao Wu used for musculoskeletal complaints, and identified larger-than-recommended dose and inadequate processing as the main determinants of risk. Substitution of raw for processed material collapses the entire safety margin: raw lateral root carries aconitine, mesaconitine and hypaconitine at hundreds of mg/kg, against a pharmacopoeial ceiling of 0.020 percent (200 mg/kg) for the sum of all three in the processed slice.

Clinical note: Sum the aconite-type drugs across the whole prescription rather than checking each in isolation. Confirm the supplied material is a pharmacopoeial processed grade (Yan Fu Zi, Hei Shun Pian, Bai Fu Pian, Pao Fu Pian or Dan Fu Zi) with a certificate showing total diester alkaloids not exceeding 0.020 percent, and reject uncharacterised slices.

Aromatic herbs added late in the decoction (Bo He, Sha Ren, Mu Xiang) or any co-formulation that shortens the total boil

Major Evidence: Established

The diester-to-monoester hydrolysis that detoxifies aconite continues in the pot, so how long the formula is boiled determines how much diester alkaloid the patient actually swallows. Diester alkaloid concentration in the aqueous extract falls rapidly in the first phase of decoction and stabilises at a low level only after about 4 hours, with monoester alkaloid content peaking between 4 and 6 hours. Standard practice is therefore to boil the aconite slices for 1-2 hours before the rest of the formula is added. Any instruction that shortens the boil, including combining aconite in a single pot with volatile aromatics that are conventionally added in the last few minutes, undermines that. Surveillance of herb-induced aconitine poisoning identifies excess dose and inadequate processing or preparation as the two determinants of poisoning, and notes that patients need to be able to follow the decoction instructions at home.

Clinical note: Write staged decoction instructions explicitly: boil the aconite slices alone for at least 1-2 hours, then add the remaining herbs, and add volatile aromatics only at the end. Confirm the patient can actually do this before dispensing; a patient who boils everything together for 20 minutes has taken a different and more dangerous drug than the one prescribed. Never dispense aconite as a powder, tincture or cold-infusion preparation, which bypass hydrolysis entirely.

Beta-adrenoceptor blockers

Moderate Evidence: Possible

Higenamine, the benzylisoquinoline alkaloid responsible for much of the positive inotropic effect, is a dual beta-1 and beta-2 adrenoceptor agonist and is heat-stable, so it survives the processing that destroys the diester alkaloids. A beta-blocker will blunt the cardiotonic action that is the point of the herb in yang-collapse and heart-failure indications, and conversely the herb supplies a low-level beta-agonist stimulus to a patient in whom beta-blockade is the therapeutic goal.

Clinical note: Expect reduced apparent efficacy in beta-blocked patients rather than a safety event. Separately, higenamine has been on the WADA Prohibited List as a beta-2 agonist since 2017, prohibited both in and out of competition, so this herb should not be given to a drug-tested athlete.

Dosage

Form Amount Frequency Duration Population Notes
n/a See Zhi Fu Zi — — — 蜀附 (Shu Fu) is not a separate pharmacopoeial article: 蜀 is the ancient name for Sichuan, and the term denotes Fu Zi of Jiangyou/Sichuan origin. Identical drug to Zhi Fu Zi (Aconiti Lateralis Radix Praeparata) — dose from that record, 3–15 g pre-decocted. This entry is pending merge into Zhi Fu Zi.

Evidence Tier

Moderate evidence · 6 studies

Recorded studies by study design, strongest design at the top. This is a study-design tier only, not a GRADE rating: it does not weigh risk of bias, consistency or precision.

Verified: design read from PubMed for a DOI that resolves to the cited paper Unverified: taken from the study's recorded description

Clinical Studies

Efficacy and Safety of Fuzi Formulae on the Treatment of Heart Failure as Complementary Therapy: A Systematic Review and Meta-Analysis of High-Quality Randomized Controlled Trials

Yang MQ, Song YM, Gao HY, Xue YT (2019) Evidence-Based Complementary and Alternative Medicine systematic review Verified: Other / unclassified

Meta-analysis of randomised controlled trials in which formulae containing processed Aconitum carmichaelii lateral root were added to conventional heart failure therapy. The pooled trials reported improvement in clinical efficacy measures alongside standard treatment. The evidence base is drawn almost entirely from Chinese-language trials with heterogeneous formulae in which Fuzi is one ingredient among several, so the result supports Fuzi-containing formulae as adjuncts rather than establishing an effect of the single herb.

Incidence of Herb-Induced Aconitine Poisoning in Hong Kong

Chan TYK (2002) Drug Safety cohort

Surveillance of accidental aconitine poisoning admitted to Hong Kong public hospitals, undertaken to assess whether publicity measures aimed at herbalists and the public reduced incidence. Thirty-one patients were treated for aconite root poisoning between 1989 and 1991 with two deaths from ventricular arrhythmia; across the longer reporting period 30 cases with three fatalities were recorded. The exposures were principally Chuan Wu and Cao Wu prescribed for musculoskeletal complaints, and the identified determinants of poisoning were excess dose and inadequate processing or preparation of the decoction.

Investigation of the drug-drug interaction and incompatibility mechanism between Aconitum carmichaelii Debx and Pinellia ternata (Thunb.) Breit

Ge M, Ouyang H, Shang Y, Biu AM, Wu X, Li C, et al. (2024) Journal of Ethnopharmacology animal Verified: In vitro / animal

Rat pharmacokinetic and enzyme study of the classical Aconitum-Pinellia incompatibility. Pinellia ternata altered cytochrome P450 activity and consequently the metabolism of the toxic Aconitum alkaloids, with the incompatibility attributed to increased in vivo absorption of those compounds. This is the strongest mechanistic support for treating the shi ba fan prohibition on this pair as a real pharmacological interaction rather than only a textual convention.

Studies on the Incompatibility between Bulbus fritillariae and Radix aconiti praeparata Based on the P-gp

Liu W, Wei L, Kanai Y, He X (2021) Evidence-Based Complementary and Alternative Medicine in vitro

Transport and expression study of the Aconitum-Fritillaria incompatibility. Combined with Fritillaria bulb, the processed aconite alkaloid benzoylmesaconine showed higher intestinal permeability; Fritillaria inhibited both the function and the expression of P-glycoprotein, with peimine, peimisine and imperialine identified as the inhibiting alkaloids. The finding gives the classical prohibition a specific efflux-transporter mechanism.

Ester Hydrolysis Differentially Reduces Aconitine-Induced Anti-hypersensitivity and Acute Neurotoxicity: Involvement of Spinal Microglial Dynorphin Expression and Implications for Aconitum Processing

Li TF, Gong N, Wang YX (2016) Frontiers in Pharmacology animal

Rodent comparison of aconitine with its hydrolysis products. Ester hydrolysis reduced acute neurotoxicity far more than it reduced antinociceptive activity, so the diester-to-monoester conversion achieved by processing separates the therapeutic effect from the toxic one rather than simply weakening the drug. The study provides the pharmacological rationale for why correctly processed Fu Zi can retain analgesic activity while losing most of its lethality.

Quantification and Simplified Detoxification Investigation on Fuzi, Root of Aconitum carmichaelii

Lai YC, Tai CJ, El-Shazly M, Chuang YC, Chiang ST, Tsai YH, et al. (2019) Natural Product Communications in vitro

Analytical study of a simplified detoxification protocol. After boiling for 8 minutes, soaking and rinsing four times over 24 hours, steaming for 3 hours and drying at 60 degrees Celsius for 7.5 hours, hypaconitine and aconitine in the processed slices fell below the limit of detection. The paper is useful chiefly for putting concrete times and temperatures on what processing has to achieve.

⚠ Rule-Based Cautions

These entries come from the deterministic rule tables that gate Verscienta's formula tools — classical pair prohibitions, pregnancy and lactation contraindications, and dose ceilings.

Incompatibilities (十八反 / 十九畏)

  • 十八反: Wu Tou × Ban Xia — avoid combining with Ban Xia / Pinellia (pair accepted when both members are processed)
  • 十八反: Wu Tou × Gua Lou — avoid combining with Gua Lou / Trichosanthes / Tian Hua Fen
  • 十八反: Wu Tou × Bei Mu — avoid combining with Bei Mu / Fritillaria / Chuan Bei / Zhe Bei
  • 十八反: Wu Tou × Bai Lian — avoid combining with Bai Lian / Ampelopsis
  • 十八反: Wu Tou × Bai Ji — avoid combining with Bai Ji / Bletilla

Pregnancy

Avoid toxic aconite

Breastfeeding

Avoid toxic to infant

Dose Ceiling

≤15g — prepared aconite 3–15g and must be pre-decocted; higher risks toxicity

Historical Texts

Shen Nong Ben Cao Jing (Divine Husbandman's Classic of Materia Medica)

Eastern Han dynasty, compiled c. 200 CE
Places Fu Zi in the lower class of drugs and marks it as gravely toxic, the classification reserved for agents used for acute intervention rather than long-term tonification. The classic treats Fu Zi and Wu Tou as related but separate entries, which is the earliest statement of the distinction this record depends on: Fu Zi is the lateral or daughter root, Wu Tou the mother root. Shu Fu is a prescription-level name for the cooked form of the former, not a separate botanical drug.

Shang Han Lun (Treatise on Cold Damage Disorders), Zhang Zhongjing

Eastern Han dynasty, c. 200-220 CE
The source of the principal aconite formulae still in use, including Si Ni Tang, Zhen Wu Tang and Fu Zi Tang. Critically, it already specifies the preparation in the formula text, distinguishing sheng Fu Zi (raw) used to rescue devastated yang from pao Fu Zi (blast-fried) used to warm the channels. The prescription name Shu Fu, cooked aconite, belongs to this same tradition of naming the processing grade in the formula rather than leaving it to the pharmacy, and in modern dispensing it is filled with a pharmacopoeial processed grade, most often Hei Shun Pian or Pao Fu Pian.

Lei Gong Pao Zhi Lun (Master Lei's Treatise on Drug Processing), attributed to Lei Xiao

Southern and Northern Dynasties, c. 5th century CE
The earliest surviving systematic processing manual, giving soaking, boiling and roasting procedures for the toxic drugs including aconite. It records the empirical discovery that prolonged wet heat renders aconite usable roughly fourteen centuries before the diester-to-monoester hydrolysis was characterised chemically.

Ru Men Shi Qin (Confucians' Duties to Their Parents), Zhang Congzheng

Jin dynasty, c. 1228
Carries the earliest recorded form of the shi ba fan (eighteen incompatibilities) mnemonic, whose first line names Ban Xia, Gua Lou, Bei Mu, Bai Lian and Bai Ji as opposing the Wu Tou group, which includes Fu Zi. For this genus the prohibition has since acquired a specific pharmacological basis in cytochrome P450 and P-glycoprotein effects on aconite alkaloid absorption, which is not true of every pair in the rhyme.

Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen

Ming dynasty, 1596
Sorts the Aconitum drugs by root morphology, separating Fu Zi (lateral root), Wu Tou (mother root), Tian Xiong and Ce Zi, and describes processing with brine and with heat. It is the reference point for the modern pharmacopoeial split into Yan Fu Zi, Hei Shun Pian and Bai Fu Pian, which are salt-cured and heat-processed grades of the same lateral root.

References

  1. Chan TYK. Aconite poisoning . Clinical Toxicology (2009) [DOI]
  2. Chan YT, Wang N, Feng Y. The toxicology and detoxification of Aconitum: traditional and modern views . Chinese Medicine (2021) [DOI]
  3. Wu Z, Qian J, Feng C, Chen Z, Gao X, Liu Y, et al.. A review of Aconiti Lateralis Radix Praeparata (Fuzi) for kidney disease: phytochemistry, toxicology, herbal processing, and pharmacology . Frontiers in Pharmacology (2024) [DOI]
  4. He G, Wang X, Liu W, Li Y, Shao Y, Liu W, et al.. Chemical constituents, pharmacological effects, toxicology, processing and compatibility of Fuzi (lateral root of Aconitum carmichaelii Debx): A review . Journal of Ethnopharmacology (2023) [DOI]
  5. Wang M, Hu WJ, Zhou X, Yu K, Wang Y, Yang BY, et al.. Ethnopharmacological use, pharmacology, toxicology, phytochemistry, and progress in Chinese crude drug processing of the lateral root of Aconitum carmichaelii Debeaux. (Fuzi): A review . Journal of Ethnopharmacology (2023) [DOI]
  6. Gao X, Hu J, Zhang X, Zuo Y, Wang Y, Zhu S. Research progress of aconitine toxicity and forensic analysis of aconitine poisoning . Forensic Sciences Research (2018) [DOI]
  7. Zhang J, Li D, Zhong D, Zhou Q, Yin Y, Gao J, et al.. Processed lateral root of Aconitum carmichaelii Debx.: A review of cardiotonic effects and cardiotoxicity on molecular mechanisms . Frontiers in Pharmacology (2022) [DOI]
  8. Wang KT, Lee MC, Chuang WC. Survey of Aconitum Alkaloids to Establish an Aconitum carmichaeli (Fu-Zi) Processing Procedure and Quality Index . Chemistry (2025) [DOI]
  9. Hudzik TJ, Patel M, Brown A. β2-Adrenoceptor agonist activity of higenamine . Drug Testing and Analysis (2021) [DOI]

This information is for educational purposes only and is not intended to replace professional medical advice. Always consult a qualified healthcare provider before using any herbal remedy, especially if you are pregnant, nursing, or taking medications.

📝 Notes

Public notes from the community and your own private notes on Shu Fu.

No notes yet.

Log in or register to add your own notes.

Back to Herb Database